EMILY GARDNER: Open Payments
NPI 1689054306 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 36 payments from 24 companies in 2025. Trend: 2023 $581 · 2024 $2,235 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| Genentech USA, Inc. | 4 | $101 |
| Daiichi Sankyo Inc. | 3 | $77 |
| ABBVIE INC. | 2 | $66 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Eisai Inc. | 2 | $43 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $39 |
| Bard Peripheral Vascular, Inc. | 1 | $39 |
| Geron Corporation | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
Products named: Venclexta, Enhertu, KEYTRUDA, Lenvima, NERLYNX, Trek, KISQALI, RYTELO.
Industry payments across VA — which companies pay providers there.
